• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌的住院负担及影响住院死亡率和住院时间的因素分析

Inpatient burden of esophageal cancer and analysis of factors affecting in-hospital mortality and length of stay.

作者信息

Sarvepalli S, Garg S K, Sarvepalli S S, Parikh M P, Wadhwa V, Jang S, Thota P N, Sanaka M R

机构信息

Department of Hospital Medicine, Medicine Institute.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

出版信息

Dis Esophagus. 2018 Sep 1;31(9). doi: 10.1093/dote/doy022.

DOI:10.1093/dote/doy022
PMID:29617798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7055505/
Abstract

Esophageal cancer (EC) continues to be a major source of morbidity and mortality in the United States. However, there has been a relative dearth of research into hospital utilization in patients with EC. This study examines temporal trends in hospital admissions, length of stay (LOS), mortality, and costs associated with EC. In addition, we also analyzed factors associated with inpatient mortality and LOS. We interrogated National Inpatient Sample (NIS), a large registry of inpatient data, to retrieve information about various demographic and factors associated with hospital stay in patients who were admitted for EC between the years 1998 and 2013 in the United States. After examining trends over time, multivariate analysis was performed to identify factors associated with LOS and mortality. During 1998-2013, 538,776 hospital stays with principal diagnosis of EC were reviewed. Number of hospital stays and inpatient charges increased by 397 per year (±67.8; P < 0.0001) and $3,033 per patient per year (±135; <0.0001) respectively. Mortality and LOS decreased by 0.23% per year (±0.03; P < 0.0001) and 0.07 days per year (±0.006; P < 0.0001) respectively. Multiple factors associated with LOS and mortality were outlined. Despite overall increase in hospital utilization with respect to number of admissions and inpatient charges, inpatient mortality and LOS associated with EC declined. Factors associated with inpatient mortality and LOS may help drive clinical decision-making and influence healthcare or hospital policy.

摘要

食管癌(EC)在美国仍然是发病和死亡的主要原因。然而,针对食管癌患者的医院利用情况的研究相对较少。本研究调查了食管癌患者的住院时间趋势、住院时长(LOS)、死亡率以及相关费用。此外,我们还分析了与住院死亡率和住院时长相关的因素。我们查询了国家住院样本(NIS),这是一个大型住院患者数据登记库,以获取1998年至2013年间在美国因食管癌入院患者的各种人口统计学信息以及与住院相关的因素。在研究了随时间的趋势后,进行了多变量分析以确定与住院时长和死亡率相关的因素。在1998 - 2013年期间,共审查了538,776例以食管癌为主要诊断的住院病例。住院次数和住院患者费用分别以每年397次(±67.8;P < 0.0001)和每位患者每年3,033美元(±135;<0.0001)的速度增长。死亡率和住院时长分别以每年0.23%(±0.03;P < 0.0001)和每年0.07天(±0.006;P < 0.0001)的速度下降。概述了与住院时长和死亡率相关的多个因素。尽管在入院次数和住院患者费用方面医院利用总体有所增加,但与食管癌相关的住院死亡率和住院时长却有所下降。与住院死亡率和住院时长相关的因素可能有助于推动临床决策制定并影响医疗保健或医院政策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2b/7263702/f35878610c19/doy022fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2b/7263702/6a877550e16d/doy022fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2b/7263702/8ca865f57d69/doy022fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2b/7263702/1491b5ecbe17/doy022fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2b/7263702/dc5fce785069/doy022fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2b/7263702/f35878610c19/doy022fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2b/7263702/6a877550e16d/doy022fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2b/7263702/8ca865f57d69/doy022fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2b/7263702/1491b5ecbe17/doy022fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2b/7263702/dc5fce785069/doy022fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2b/7263702/f35878610c19/doy022fig5.jpg

相似文献

1
Inpatient burden of esophageal cancer and analysis of factors affecting in-hospital mortality and length of stay.食管癌的住院负担及影响住院死亡率和住院时间的因素分析
Dis Esophagus. 2018 Sep 1;31(9). doi: 10.1093/dote/doy022.
2
Hospital Utilization in Patients With Gastric Cancer and Factors Affecting In-Hospital Mortality, Length of Stay, and Costs.胃癌患者的医院利用情况以及影响住院死亡率、住院时间和费用的因素。
J Clin Gastroenterol. 2019 Apr;53(4):e157-e163. doi: 10.1097/MCG.0000000000001016.
3
Hospitalization costs of cystic fibrosis in the United States: a retrospective analysis.美国囊性纤维化的住院费用:一项回顾性分析。
Hosp Pract (1995). 2018 Oct;46(4):203-213. doi: 10.1080/21548331.2018.1505407. Epub 2018 Aug 9.
4
Economic and survival burden of dysphagia among inpatients in the United States.美国住院患者吞咽困难的经济负担和生存负担。
Dis Esophagus. 2018 Jan 1;31(1):1-7. doi: 10.1093/dote/dox131.
5
Factors Contributing to Hospital Stay and Total Inpatient Charges in Total Ankle Arthroplasty: Review of the National Inpatient Sample.全踝关节置换术中影响住院时间和住院总费用的因素:对国家住院样本的回顾
Foot Ankle Spec. 2018 Jun;11(3):230-235. doi: 10.1177/1938640017720748. Epub 2017 Jul 8.
6
Mortality, length of stay and cost of hospitalization among patients with systemic sclerosis: results from the National Inpatient Sample.系统性硬化症患者的死亡率、住院时间和住院费用:来自全国住院患者样本的结果。
Rheumatology (Oxford). 2018 Sep 1;57(9):1611-1622. doi: 10.1093/rheumatology/key150.
7
Mortality, length of stay, and inpatient charges for heart failure patients at public versus private hospitals in South Korea.韩国公立医院与私立医院中心力衰竭患者的死亡率、住院时间及住院费用。
Yonsei Med J. 2015 May;56(3):853-61. doi: 10.3349/ymj.2015.56.3.853.
8
Healthcare Costs and Utilization among Patients Hospitalized for Malignant Pleural Effusion.恶性胸腔积液住院患者的医疗费用和利用情况。
Respiration. 2020;99(3):257-263. doi: 10.1159/000506210. Epub 2020 Mar 10.
9
The inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sample.2005 年至 2009 年肝癌患者的住院经济和死亡率影响:美国全国住院患者样本分析。
Liver Int. 2013 Sep;33(8):1281-6. doi: 10.1111/liv.12201. Epub 2013 May 26.
10
National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.子宫肌瘤手术住院费用和住院时长的全国趋势及影响因素。
J Health Care Finance. 2007 Spring;33(3):1-16.

引用本文的文献

1
Intensive care unit outcomes and prognostic factors of esophageal cancer: A cross-sectional study in Chinese cancer-specialized hospitals.食管癌重症监护病房的结局及预后因素:一项在中国癌症专科医院开展的横断面研究。
World J Gastrointest Oncol. 2025 Aug 15;17(8):106688. doi: 10.4251/wjgo.v17.i8.106688.
2
Does Prehabilitation Reduce Postoperative Length of Hospital Stay after Esophageal Cancer Surgery?术前康复能否缩短食管癌手术后的住院时间?
Prog Rehabil Med. 2024 Apr 10;9:20240013. doi: 10.2490/prm.20240013. eCollection 2024.
3
Estimating the Time Toxicity of Contemporary Systemic Treatment Regimens for Advanced Esophageal and Gastric Cancers.

本文引用的文献

1
Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service.按肿瘤分期和服务类型比较乳腺癌的治疗成本
Am Health Drug Benefits. 2016 Feb;9(1):23-32.
2
Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis.1973年至2009年美国成年人食管癌生存率趋势:一项监测、流行病学和最终结果(SEER)数据库分析
J Gastroenterol Hepatol. 2016 Jun;31(6):1141-6. doi: 10.1111/jgh.13289.
3
Cancer statistics, 2016.癌症统计数据,2016 年。
评估当代晚期食管癌和胃癌全身治疗方案的时间毒性
Cancers (Basel). 2023 Nov 30;15(23):5677. doi: 10.3390/cancers15235677.
4
Effects of unimodal or multimodal prehabilitation on patients undergoing surgery for esophagogastric cancer: a systematic review and meta-analysis.单一模式或多模式术前康复对行食管胃交界癌手术患者的影响:系统评价和荟萃分析。
Support Care Cancer. 2023 Dec 7;32(1):15. doi: 10.1007/s00520-023-08229-w.
5
Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett's Esophagus, and Barrett's Esophagus-Related Neoplasia in the United States.美国胃食管反流病、巴雷特食管及巴雷特食管相关肿瘤患者的医疗资源利用情况及费用
J Health Econ Outcomes Res. 2023 Mar 3;10(1):51-58. doi: 10.36469/001c.68191. eCollection 2023.
6
Dynamic monitoring revealed a slightly prolonged waiting time for total gastrectomy during the COVID-19 pandemic without increasing the short-term complications.动态监测显示,在新冠疫情期间,全胃切除术的等待时间略有延长,但短期并发症并未增加。
Front Oncol. 2022 Aug 31;12:944602. doi: 10.3389/fonc.2022.944602. eCollection 2022.
7
Burden of in-hospital care in oesophageal cancer: national population-based study.食管癌住院治疗负担:全国基于人群的研究。
BJS Open. 2021 May 7;5(3). doi: 10.1093/bjsopen/zrab037.
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
4
Involvement of a Case Manager in Palliative Care Reduces Hospitalisations at the End of Life in Cancer Patients; A Mortality Follow-Back Study in Primary Care.病例管理员参与姑息治疗可减少癌症患者临终时的住院次数;一项初级保健中的死亡率回顾研究。
PLoS One. 2015 Jul 24;10(7):e0133197. doi: 10.1371/journal.pone.0133197. eCollection 2015.
5
Does the Medicare 3-Day Rule Increase Length of Stay?医疗保险的三天规定会增加住院时长吗?
J Arthroplasty. 2015 Sep;30(9 Suppl):34-5. doi: 10.1016/j.arth.2015.06.008. Epub 2015 Jun 12.
6
Advances in targeted therapies and new promising targets in esophageal cancer.食管癌靶向治疗的进展及新的有前景的靶点
Oncotarget. 2015 Jan 30;6(3):1348-58. doi: 10.18632/oncotarget.2752.
7
Health care costs for patients with cancer at the end of life.终末期癌症患者的医疗保健费用。
J Oncol Pract. 2012 Nov;8(6):75s-80s. doi: 10.1200/JOP.2011.000469. Epub 2012 Jul 3.
8
Treatments for esophageal cancer: a review.食管癌的治疗:综述
Gen Thorac Cardiovasc Surg. 2013 Jun;61(6):330-5. doi: 10.1007/s11748-013-0246-0. Epub 2013 Apr 9.
9
Trends in esophageal adenocarcinoma incidence and mortality.食管腺癌发病率和死亡率的趋势。
Cancer. 2013 Mar 15;119(6):1149-58. doi: 10.1002/cncr.27834. Epub 2012 Dec 11.
10
Multimodal treatment of esophageal cancer.食管癌的多模态治疗。
Langenbecks Arch Surg. 2013 Feb;398(2):177-87. doi: 10.1007/s00423-012-1001-1. Epub 2012 Sep 13.